American Journal of Cardiology
Volume 103, Issue 3 , Pages 328-332 , 1 February 2009

Hematologic Parameters, Atherosclerotic Progression, and Prognosis in Patients With Previous Coronary Artery Bypass Grafting (from the Post CABG Trial)

  • Kenneth J. Mukamal, MD, MPH, MA

      Affiliations

    • Division of General Medicine and Primary Care, Beth Israel Deaconess Medical Center, Boston, Massachusetts
    • Cardiovascular Epidemiology Research Unit, Beth Israel Deaconess Medical Center, Boston, Massachusetts
    • Corresponding Author InformationCorresponding author: Tel: 617-754-1401; fax: 617-754-1440
    • ,
  • Gregory A. Wellenius, ScD

      Affiliations

    • Cardiovascular Epidemiology Research Unit, Beth Israel Deaconess Medical Center, Boston, Massachusetts
    • ,
  • Murray A. Mittleman, MD, DrPH

      Affiliations

    • Cardiovascular Epidemiology Research Unit, Beth Israel Deaconess Medical Center, Boston, Massachusetts
    • Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts

Received 18 July 2008 ,Revised 12 September 2008 ,Accepted 12 September 2008.

References 

  1. The Post Coronary Artery Bypass Graft Trial Investigators. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts. N Engl J Med. 1997;336:153–162
  2. Knatterud GL, Rosenberg Y, Campeau L, Geller NL, Hunninghake DB, Forman SA, et al Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the Post Coronary Artery Bypass Graft Trial (Post CABG Investigators). Circulation. 2000;102:157–165
  3. Domanski MJ, Borkowf CB, Campeau L, Knatterud GL, White C, Hoogwerf B, et al. Prognostic factors for atherosclerosis progression in saphenous vein grafts: the Post Coronary Artery Bypass Graft (Post-CABG) Trial (Post-CABG Trial Investigators). J Am Coll Cardiol. 2000;36:1877–1883
  4. Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA. 1998;279:1477–1482
  5. Keskin O, Ulusoy RE, Kalemoglu M, Us MH, Yildirim I, Tarcin O, et al. White blood cell count and C-reactive protein predict short-term prognosis in acute myocardial infarction. J Int Med Res. 2004;32:646–654
  6. Grzybowski M, Welch RD, Parsons L, Ndumele CE, Chen E, Zalenski R, et al. The association between white blood cell count and acute myocardial infarction in-hospital mortality: findings from the National Registry of Myocardial Infarction. Acad Emerg Med. 2004;11:1049–1060
  7. Kruk M, Karcz M, Przyluski J, Bekta P, Kepka C, Kalinczuk L, et al. White blood cell count adds prognostic information to the Thrombolysis In Myocardial Infarction risk index in patients following primary percutaneous coronary intervention (ANIN Myocardial Infarction Registry). Int J Cardiol. 2007;116:376–382
  8. Smit JJ, Ottervanger JP, Slingerland RJ, Kolkman JJ, Suryapranata H, Hoorntje JC, et al. Comparison of usefulness of C-reactive protein versus white blood cell count to predict outcome after primary percutaneous coronary intervention for ST elevation myocardial infarction. Am J Cardiol. 2008;101:446–451
  9. Carter AM. Inflammation, thrombosis and acute coronary syndromes. Diabetes Vasc Dis Res. 2005;2:113–121
  10. Croce K, Libby P. Intertwining of thrombosis and inflammation in atherosclerosis. Curr Opin Hematol. 2007;14:55–61
  11. Aso Y. Plasminogen activator inhibitor (PAI)-1 in vascular inflammation and thrombosis. Front Biosci. 2007;12:2957–2966
  12. Nikolsky E, Aymong ED, Halkin A, Grines CL, Cox DA, Garcia E, et al Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial. J Am Coll Cardiol. 2004;44:547–553
  13. McKechnie RS, Smith D, Montoye C, Kline-Rogers E, O'Donnell MJ, DeFranco AC, et al Prognostic implication of anemia on in-hospital outcomes after percutaneous coronary intervention. Circulation. 2004;110:271–277
  14. Vaglio J, Safley DM, Rahman M, Kosiborod M, Jones P, Thompson R, et al. Relation of anemia at discharge to survival after acute coronary syndromes. Am J Cardiol. 2005;96:496–499
  15. Cavusoglu E, Chopra V, Gupta A, Clark LT, Eng C, Marmur JD. Usefulness of anemia in men as an independent predictor of two-year cardiovascular outcome in patients presenting with acute coronary syndrome. Am J Cardiol. 2006;98:580–584
  16. Kulier A, Levin J, Moser R, Rumpold-Seitlinger G, Tudor IC, Snyder-Ramos SA, et al. Impact of preoperative anemia on outcome in patients undergoing coronary artery bypass graft surgery. Circulation. 2007;116:471–479
  17. Voeltz MD, Patel AD, Feit F, Fazel R, Lincoff AM, Manoukian SV. Effect of anemia on hemorrhagic complications and mortality following percutaneous coronary intervention. Am J Cardiol. 2007;99:1513–1517
  18. Singla I, Zahid M, Good CB, Macioce A, Sonel AF. Impact of blood transfusions in patients presenting with anemia and suspected acute coronary syndrome. Am J Cardiol. 2007;99:1119–1121
  19. da Silveira AD, Ribeiro RA, Rossini AP, Stella SF, Ritta HA, Stein R, et al. Association of anemia with clinical outcomes in stable coronary artery disease. Coron Artery Dis. 2008;19:21–26
  20. Johansen O, Brekke M, Seljeflot I, Semb AG, Arnesen H. Blood platelet count and reactivity are associated with restenosis 6 months after coronary angioplasty. Scand Cardiovasc J. 2004;38:211–215
  21. Nikolsky E, Grines CL, Cox DA, Garcia E, Tcheng JE, Sadeghi M, et al. Impact of baseline platelet count in patients undergoing primary percutaneous coronary intervention in acute myocardial infarction (from the CADILLAC trial). Am J Cardiol. 2007;99:1055–1061
  22. Held C, Hjemdahl P, Hakan Wallen N, Bjorkander I, Forslund L, Wiman B, et al. Inflammatory and hemostatic markers in relation to cardiovascular prognosis in patients with stable angina pectoris (Results from the APSIS study. The Angina Prognosis Study in Stockholm). Atherosclerosis. 2000;148:179–188
  23. Ly HQ, Kirtane AJ, Murphy SA, Buros J, Cannon CP, Braunwald E, et al. Association of platelet counts on presentation and clinical outcomes in ST-elevation myocardial infarction (from the TIMI trials). Am J Cardiol. 2006;98:1–5
  24. Mueller C, Neumann FJ, Hochholzer W, Trenk D, Zeller T, Perruchoud AP, et al. The impact of platelet count on mortality in unstable angina/non-ST-segment elevation myocardial infarction. Am Heart J. 2006;151:1214 e1–e7
  25. Zakai NA, Katz R, Jenny NS, Psaty BM, Reiner AP, Schwartz SM, et al. Inflammation and hemostasis biomarkers and cardiovascular risk in the elderly: the Cardiovascular Health Study. J Thromb Haemost. 2007;5:1128–1135

 The Post CABG Study was conducted and supported by the National Heart, Lung, and Blood Institute, Bethesda, Maryland, in collaboration with the Post CABG Study Investigators.

PII: S0002-9149(08)01674-3

doi: 10.1016/j.amjcard.2008.09.080

American Journal of Cardiology
Volume 103, Issue 3 , Pages 328-332 , 1 February 2009

Article Tools